Murali P, Kavitha B, Narasimhan M
J Pharm Bioallied Sci. 2025; 16(Suppl 5):S4210-S4220.
PMID: 40061651
PMC: 11888656.
DOI: 10.4103/jpbs.jpbs_517_24.
Peng Z, Zhang H, Hu H
Adv Exp Med Biol. 2024; 1466:135-159.
PMID: 39546141
DOI: 10.1007/978-981-97-7288-9_10.
Tirelli M, Bonfiglio F, Cantalupo S, Montella A, Avitabile M, Maiorino T
Hum Genet. 2024; 143(11):1293-1309.
PMID: 39192051
PMC: 11522082.
DOI: 10.1007/s00439-024-02700-2.
Li P, Wang Y, Wang X, Li R, Wang K, Jiang Y
Molecules. 2024; 29(9).
PMID: 38731488
PMC: 11085915.
DOI: 10.3390/molecules29091998.
Gross F, Mancini A, Breton B, Kobayashi H, Pereira P, Le Gouill C
Commun Biol. 2024; 7(1):250.
PMID: 38429428
PMC: 10907714.
DOI: 10.1038/s42003-024-05965-5.
The ubiquitin ligases Cbl and Cbl-b regulate macrophage growth by controlling CSF-1R import into macropinosomes.
Huang L, Thiex N, Lou J, Ahmad G, An W, Low-Nam S
Mol Biol Cell. 2024; 35(3):ar38.
PMID: 38170572
PMC: 10916879.
DOI: 10.1091/mbc.E23-09-0345.
TCR signaling promotes formation of an STS1-Cbl-b complex with pH-sensitive phosphatase activity that suppresses T cell function in acidic environments.
Tsai Y, Arias-Badia M, Kadlecek T, Lwin Y, Srinath A, Shah N
Immunity. 2023; 56(12):2682-2698.e9.
PMID: 38091950
PMC: 10785950.
DOI: 10.1016/j.immuni.2023.11.010.
E3 ubiquitin ligases in nasopharyngeal carcinoma and implications for therapies.
Zhou Z, Zheng K, Zhou S, Yang Y, Chen J, Jin X
J Mol Med (Berl). 2023; 101(12):1543-1565.
PMID: 37796337
DOI: 10.1007/s00109-023-02376-7.
PRL2 Phosphatase Promotes Oncogenic KIT Signaling in Leukemia Cells through Modulating CBL Phosphorylation.
Chen H, Bai Y, Kobayashi M, Xiao S, Barajas S, Cai W
Mol Cancer Res. 2023; 22(1):94-103.
PMID: 37756563
PMC: 10841656.
DOI: 10.1158/1541-7786.MCR-23-0115.
The roles of ubiquitination in AML.
Wei Z, Su L, Gao S
Ann Hematol. 2023; 103(9):3413-3428.
PMID: 37603061
DOI: 10.1007/s00277-023-05415-y.
STS-1 and STS-2, Multi-Enzyme Proteins Equipped to Mediate Protein-Protein Interactions.
Hayes B, van der Geer P
Int J Mol Sci. 2023; 24(11).
PMID: 37298164
PMC: 10252698.
DOI: 10.3390/ijms24119214.
B cell activation via immunometabolism in systemic lupus erythematosus.
Iwata S, Hajime Sumikawa M, Tanaka Y
Front Immunol. 2023; 14:1155421.
PMID: 37256149
PMC: 10225689.
DOI: 10.3389/fimmu.2023.1155421.
Functional roles of SRC signaling in pancreatic cancer: Recent insights provide novel therapeutic opportunities.
Poh A, Ernst M
Oncogene. 2023; 42(22):1786-1801.
PMID: 37120696
PMC: 10238273.
DOI: 10.1038/s41388-023-02701-x.
E3-ubiquitin ligases and recent progress in osteoimmunology.
Asano Y, Matsumoto Y, Wada J, Rottapel R
Front Immunol. 2023; 14:1120710.
PMID: 36911671
PMC: 9996189.
DOI: 10.3389/fimmu.2023.1120710.
Genome-Wide Analysis on Transcriptome and Methylome in Prevention of Mammary Tumor Induced by Early Life Combined Botanicals.
Arora I, Li S, Crowley M, Li Y, Tollefsbol T
Cells. 2023; 12(1).
PMID: 36611809
PMC: 9818885.
DOI: 10.3390/cells12010014.
The UBE2D ubiquitin conjugating enzymes: Potential regulatory hubs in development, disease and evolution.
Roman-Trufero M, Dillon N
Front Cell Dev Biol. 2022; 10:1058751.
PMID: 36578786
PMC: 9790923.
DOI: 10.3389/fcell.2022.1058751.
PRL2 phosphatase enhances oncogenic FLT3 signaling via dephosphorylation of the E3 ubiquitin ligase CBL at tyrosine 371.
Chen H, Bai Y, Kobayashi M, Xiao S, Cai W, Barajas S
Blood. 2022; 141(3):244-259.
PMID: 36206490
PMC: 9936309.
DOI: 10.1182/blood.2022016580.
Targeting the PTP1B-Bcr-Abl1 interaction for the degradation of T315I mutant Bcr-Abl1 in chronic myeloid leukemia.
Elgehama A, Wang Y, Yu Y, Zhou L, Chen Z, Wang L
Cancer Sci. 2022; 114(1):247-258.
PMID: 36086954
PMC: 9807508.
DOI: 10.1111/cas.15580.
SERPINA5 promotes tumour cell proliferation by modulating the PI3K/AKT/mTOR signalling pathway in gastric cancer.
Fan M, Xiong X, Han L, Zhang L, Gao S, Liu L
J Cell Mol Med. 2022; 26(18):4837-4846.
PMID: 36000536
PMC: 9465189.
DOI: 10.1111/jcmm.17514.
Protein ubiquitination in T cell development.
Zhong T, Lei K, Lin X, Xie Z, Luo S, Zhou Z
Front Immunol. 2022; 13:941962.
PMID: 35990660
PMC: 9386135.
DOI: 10.3389/fimmu.2022.941962.